IPR Enforcement: Breathing Treatment Systems, Integrated Circuits
Breathing Treatment Systems. The International Trade Commission has terminated patent infringement investigation 337-TA-997 of sleep-disordered breathing treatment systems and components thereof with respect to numerous patent claims asserted by complainants ResMed Corporation, ResMed Incorporated, and ResMed Limited based on their withdrawal of allegations pertaining to those claims.
Integrated Circuits. The ITC received Sept. 12 on behalf of R2 Semiconductor Inc. a petition requesting that it institute a Section 337 investigation regarding integrated circuits with voltage regulators and products containing same. The proposed respondents are located in Ireland, Israel, China, and the U.S.
Section 337 investigations primarily involve claims regarding intellectual property rights violations by imported goods, including the infringement of patents, trademarks and copyrights. Other forms of unfair competition involving imported products, such as misappropriation of trade secrets or trade dress and false advertising, may also be asserted. The primary remedy available in Section 337 investigations is an exclusion order that directs U.S. Customs and Border Protection to stop infringing imports from entering the U.S. In addition, the ITC may issue cease and desist orders against named importers and other persons engaged in unfair acts that violate Section 337, including selling infringing imported articles out of U.S. inventory.